| Financial Year |
March 31 2023 |
| Monetary Funds |
599,139,885.86 |
| Held-for-trading Financial Assets |
1,719,187,772.94 |
| Notes Receivable |
-- |
| Accounts Receivable |
243,129,914.47 |
| Advances to Suppliers |
4,088,314.92 |
| Other Receivables |
16,043,022.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
296,010,436.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
50,467,591.00 |
| Total Current Assets |
2,928,066,937.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
142,161,116.50 |
| Under-construction Projects |
3,476,453.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
33,272,424.59 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,339,512.92 |
| Deferred Income Tax Assets |
9,275,928.08 |
| Other Non-Current Assets |
5,340,462.32 |
| Sub-Total of Non-Current Assets |
340,614,517.43 |
| Total Assets |
3,268,681,455.40 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
73,456,000.00 |
| Accounts Payable |
213,197,715.17 |
| Accounts Received In Advance |
9,542,232.36 |
| Employee Compensation Payable |
17,242,048.57 |
| Taxes Payable |
21,094,252.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
191,264.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,025,261.33 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
369,078,660.49 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,282,049.11 |
| Deferred Income Tax Liabilities |
3,313,354.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
130,128,950.15 |
| Total Liabilities |
499,207,610.64 |
| Paid-In Capital(Or Share Stock) |
128,000,000.00 |
| Capital Surplus |
1,669,859,605.83 |
| Surplus Reserve |
32,431,432.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
926,515,982.15 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,769,473,844.76 |
| Owner's Equity（Stockholder's Equity） |
2,769,473,844.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,268,681,455.40 |
